{
    "Participant": "huA90CE6", 
    "Report URL": "http://evidence.personalgenomes.org/genomes?display_genome_id=c5c0c15780de720964e0c2ee195c8afbaeff0dc7", 
    "Variants": [
        {
            "Allele Frequency": "0.00028", 
            "Build 37 Chromosome": "chr9", 
            "Build 37 Position": "5073770", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Blood", 
                "Cancer"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "JAK2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 12, 
            "PMID List": [
                "15781101", 
                "15793561", 
                "15837627", 
                "15858187", 
                "15860661", 
                "15920007", 
                "16675710", 
                "16946305", 
                "19262599", 
                "20425436", 
                "21160067", 
                "21484303"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "4", 
                "Penetrance": "4", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This well known variant is associated with myeloproliferative diseases: it is used as a diagnostic, providing supporting evidence in individuals who already have symptoms. It is seen as an acquired (not inherited) mutation, one of an accumulation of changes that leads to the development of these cancer-like diseases. It is possible to see this variant in whole genome data or genotyping from blood-derived DNA -- but it is unclear how to view the presence of the variant in individuals who don't have symptoms of the disease. Data from Nielsen et al. suggests that such carriers are at much higher risk of developing myeloproliferative disease or other blood cancer (with roughly 50% of still-living individuals developing these diseases by around 10 years after initial samples -- but these numbers are _extremely_ uncertain).", 
            "URL": "http://evidence.pgp-hms.org/JAK2-V617F", 
            "Variant Name": "JAK2-V617F", 
            "Variant Page": "http://evidence.pgp-hms.org/JAK2-V617F", 
            "dbSNP IDs": [
                "rs77375493"
            ]
        }, 
        {
            "Allele Frequency": "0.14", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "45411941", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "High", 
            "Condition Tags": [
                "Mental and behavioral", 
                "Nervous system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "APOE", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "9343467", 
                "11950276", 
                "15123497", 
                "17428983"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": "3", 
                "Penetrance": "4", 
                "Severity": "4", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is generally known as the ApoE4 allele of ApoE and is associated with increased risk of Alzheimer's. 20-25% of individuals are heterozygous for this variant, and 1-2% are homozygous. Data from Khachaturian et al. suggests an average 7% of all individuals developed Alzheimer's by the age of 80; when this is split by ApoE4 status: 10% of ApoE4 heterozygotes (3% increased attributable risk), 40% of ApoE4 homozygotes (33% increased attributable risk), and 5% of non-carriers (2% decreased attributable risk). Notably, their model suggests 70-75% of people would eventually develop Alzheimer's by the age of 100 regardless of ApoE4 genotype (and 25-30% are resistant, regardless of genotype), but that ApoE4 variants shift the disease onset to occur significantly earlier (4 years earlier for heterozygous carriers, 13 years for homozygotes).", 
            "URL": "http://evidence.pgp-hms.org/APOE-C130R", 
            "Variant Name": "APOE-C130R", 
            "Variant Page": "http://evidence.pgp-hms.org/APOE-C130R", 
            "dbSNP IDs": [
                "rs429358"
            ]
        }, 
        {
            "Allele Frequency": "0.15", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "6718387", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "C3", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "4427677", 
                "17634448"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant (also called C3F) is common in Europeans (10.2% allele frequency), and is associated with age-related macular degeneration. In the US, 1.5% of adults over 40 have the disease, but the incidence increases strongly with age (>15% in women over 80). Assuming an average lifetime risk of ~10%, heterozygous individuals have a ~13% risk and homozygous have ~20%.", 
            "URL": "http://evidence.pgp-hms.org/C3-R102G", 
            "Variant Name": "C3-R102G", 
            "Variant Page": "http://evidence.pgp-hms.org/C3-R102G", 
            "dbSNP IDs": [
                "rs2230199"
            ]
        }, 
        {
            "Allele Frequency": "0.089", 
            "Build 37 Chromosome": "chr3", 
            "Build 37 Position": "12393125", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PPARG", 
            "Impact": "Not Reviewed", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "16783862", 
                "17213274", 
                "17463248"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "3", 
                "Familial": "1", 
                "Functional": "1", 
                "Penetrance": "3", 
                "Severity": "3", 
                "Treatability": "2"
            }, 
            "Status": "Heterozygous", 
            "Summary": null, 
            "URL": "http://evidence.pgp-hms.org/PPARG-P12A", 
            "Variant Name": "PPARG-P12A", 
            "Variant Page": "http://evidence.pgp-hms.org/PPARG-P12A", 
            "dbSNP IDs": [
                "rs1801282"
            ]
        }, 
        {
            "Allele Frequency": "0.017", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "113283484", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Mental and behavioral"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "DRD2", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 6, 
            "PMID List": [
                "7907680", 
                "8824240", 
                "9650635", 
                "12707934", 
                "16402354", 
                "17651483"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": "2", 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "Various studies report this variant in a dopamine receptor is associated with increased risk for schizophrenia. Assuming an average 1% chance of schizophrenia in the general population, combined data suggests carriers of this variant have a risk of 1.4% (0.4% increased risk above average).", 
            "URL": "http://evidence.pgp-hms.org/DRD2-S311C", 
            "Variant Name": "DRD2-S311C", 
            "Variant Page": "http://evidence.pgp-hms.org/DRD2-S311C", 
            "dbSNP IDs": [
                "rs1801028"
            ]
        }, 
        {
            "Allele Frequency": "0.093", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "115236057", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism", 
                "Muscular, skeletal, and connective tissue"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "AMPD1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "1631143"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "4", 
                "Severity": "2", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Causes Adenosine Deaminase Deficiency in a recessive manner. Most of the time individuals do not report symptoms, but when symptoms do exist they to be post-exercise symptoms of muscle weakness, muscle pain, and getting tired more quickly.", 
            "URL": "http://evidence.pgp-hms.org/AMPD1-Q12X", 
            "Variant Name": "AMPD1-Q12X", 
            "Variant Page": "http://evidence.pgp-hms.org/AMPD1-Q12X", 
            "dbSNP IDs": [
                "rs17602729"
            ]
        }, 
        {
            "Allele Frequency": "0.016", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "43620335", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RET", 
            "Impact": "Pathogenic", 
            "Inheritance": "Dominant", 
            "PMID Count": 4, 
            "PMID List": [
                "7647787", 
                "7881414", 
                "9760196", 
                "14633923"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": "-1", 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Initially suspected of causing Hirschsprung\u2019s disease, this rare variant has been later reported as present in unaffected controls (allele frequency around 1%). Supporting a lack of effect: Panini et al. did not find loss of function effects seen in other variants, and Svensson et al. report unaffected relatives in a family who carried the same variant. OMIM lists it as reported to cause increased susceptibility, but there do not appear to be any statistically significant reports supporting this hypothesis.", 
            "URL": "http://evidence.pgp-hms.org/RET-R982C", 
            "Variant Name": "RET-R982C", 
            "Variant Page": "http://evidence.pgp-hms.org/RET-R982C", 
            "dbSNP IDs": [
                "rs17158558"
            ]
        }, 
        {
            "Allele Frequency": "0.28", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "182554557", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer", 
                "Genital and urinary"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RNASEL", 
            "Impact": "Pathogenic", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 4, 
            "PMID List": [
                "11941539", 
                "12022038", 
                "12415269", 
                "17407163"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Associated with increased risk of prostate cancer in individuals who already have a family history of prostate cancer, but studies have been unable to replicate this finding in sporadic (non-familial) prostate cancer cases.", 
            "URL": "http://evidence.pgp-hms.org/RNASEL-R462Q", 
            "Variant Name": "RNASEL-R462Q", 
            "Variant Page": "http://evidence.pgp-hms.org/RNASEL-R462Q", 
            "dbSNP IDs": [
                "rs486907"
            ]
        }, 
        {
            "Allele Frequency": "0.63", 
            "Build 37 Chromosome": "chr17", 
            "Build 37 Position": "7579472", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TP53", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "1975675", 
                "9607760", 
                "15355915", 
                "19837266", 
                "20615891", 
                "22184967"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.", 
            "URL": "http://evidence.pgp-hms.org/TP53-P72R", 
            "Variant Name": "TP53-P72R", 
            "Variant Page": "http://evidence.pgp-hms.org/TP53-P72R", 
            "dbSNP IDs": [
                "rs1042522"
            ]
        }, 
        {
            "Allele Frequency": "0.4", 
            "Build 37 Chromosome": "chr4", 
            "Build 37 Position": "6303354", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision", 
                "Immune system", 
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "WFS1", 
            "Impact": "Not Reviewed", 
            "Inheritance": "Recessive", 
            "PMID Count": 3, 
            "PMID List": [
                "17603484", 
                "17719176", 
                "23257691"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "4", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "1", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).", 
            "URL": "http://evidence.pgp-hms.org/WFS1-R611H", 
            "Variant Name": "WFS1-R611H", 
            "Variant Page": "http://evidence.pgp-hms.org/WFS1-R611H", 
            "dbSNP IDs": [
                "rs734312"
            ]
        }, 
        {
            "Allele Frequency": "0.036", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "101829514", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "CPN1", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 1, 
            "PMID List": [
                "12560874"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": "5", 
                "Severity": "2", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This rare variant (around 1% allele frequency) is hypothesized to cause carboxypeptidase N deficiency in a recessive manner, especially if combined with a more severe variant. However the findings lack statistical sigificance: only a single case study of an affected individual links this variant to causing the disease. There aren\u2019t any follow-up in vitro studies testing whether this variant affects protein function.", 
            "URL": "http://evidence.pgp-hms.org/CPN1-G178D", 
            "Variant Name": "CPN1-G178D", 
            "Variant Page": "http://evidence.pgp-hms.org/CPN1-G178D", 
            "dbSNP IDs": [
                "rs61751507"
            ]
        }, 
        {
            "Allele Frequency": "0.0044", 
            "Build 37 Chromosome": "chr22", 
            "Build 37 Position": "18909902", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Mental and behavioral", 
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PRODH", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12217952", 
                "15662599"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": "1", 
                "Penetrance": "2", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "One report suggested that this rare variant (0.9% allele frequency) could be associated with hyperprolinemia and, through this, associated with increased susceptibility to schizophrenia and/or schizoaffective disorder. However, this finding completely lacked statistical significance, and both reported cases were also associated with other potentially causal variants. A later functional study found only a mild functional effect on enzyme activity (78-90% of wildtype activity).", 
            "URL": "http://evidence.pgp-hms.org/PRODH-L289M", 
            "Variant Name": "PRODH-L289M", 
            "Variant Page": "http://evidence.pgp-hms.org/PRODH-L289M"
        }, 
        {
            "Allele Frequency": "0.11", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "26091179", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "HFE", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 5, 
            "PMID List": [
                "8696333", 
                "9462220", 
                "12429850", 
                "14673107", 
                "17042772"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": "2", 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "5"
            }, 
            "Status": "Heterozygous", 
            "Summary": "There have been some hypotheses that this variant contributes to causing hereditary hemochromatosis, possibly as a compound heterozygote, but some others treat it as a polymorphism. Cys282Tyr is the classic causal variant and itself has very low penetrance. Mouse studies indicates this variant has a similar but weaker effect; if it has any effect at all its penetrance may be quite low and/or require modifier alleles.", 
            "URL": "http://evidence.pgp-hms.org/HFE-H63D", 
            "Variant Name": "HFE-H63D", 
            "Variant Page": "http://evidence.pgp-hms.org/HFE-H63D", 
            "dbSNP IDs": [
                "rs1799945"
            ]
        }, 
        {
            "Allele Frequency": "0.86", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "231050715", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SP110", 
            "Impact": "Pathogenic", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "16803959"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "0", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.", 
            "URL": "http://evidence.pgp-hms.org/SP110-L425S", 
            "Variant Name": "SP110-L425S", 
            "Variant Page": "http://evidence.pgp-hms.org/SP110-L425S", 
            "dbSNP IDs": [
                "rs3948464"
            ]
        }, 
        {
            "Allele Frequency": "0.2", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "50678369", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital", 
                "Cancer", 
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ERCC6", 
            "Impact": "Pathogenic", 
            "Inheritance": "Recessive", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "3", 
                "Familial": "0", 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "5", 
                "Treatability": "1"
            }, 
            "Status": "Heterozygous", 
            "Summary": "When homozygous, this variant may cause Cockayne Syndrome, which is a severe autosomal-recessive disorder characterized by abnormal early growth and development, abnormal sensitivity to sunlight, and premature aging. Cockayne Syndrome Type I and Type II lead to death in early childhood. Several other variants in the ERCC6 gene are linked to Cockayne Syndrome. This variant may also be linked to age-related macular degeneration like other ERCC6 variants, and has been linked to colorectal cancer in one study. ", 
            "URL": "http://evidence.pgp-hms.org/ERCC6-R1213G", 
            "Variant Name": "ERCC6-R1213G", 
            "Variant Page": "http://evidence.pgp-hms.org/ERCC6-R1213G", 
            "dbSNP IDs": [
                "rs2228527"
            ]
        }, 
        {
            "Allele Frequency": "0.011", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "148206885", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Drug response", 
                "Heart and circulatory"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "ADRB2", 
            "Impact": "Pharmacogenetic", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "7901205", 
                "18353108"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": "4", 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "This rare variant in \u03b22-Adrenoceptor has only reported heterozygously (in 2-4% of the population) and strongly decreases the protein\u2019s responsiveness to inducing compounds (agonists). Carriers of this variant are less sensitive to induction of increased heart rate, heart contraction, and vasodilation by \u03b2-AR agonists. Mixed data suggests that this variant does not have a significant impact on hypertension or heart disease. It may affect responsiveness to beta blocker drugs.", 
            "URL": "http://evidence.pgp-hms.org/ADRB2-T164I", 
            "Variant Name": "ADRB2-T164I", 
            "Variant Page": "http://evidence.pgp-hms.org/ADRB2-T164I", 
            "dbSNP IDs": [
                "rs1800888"
            ]
        }, 
        {
            "Allele Frequency": "0.49", 
            "Build 37 Chromosome": "chr19", 
            "Build 37 Position": "49206674", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Moderate", 
            "Condition Tags": [
                "Blood", 
                "Immune system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "FUT2", 
            "Impact": "Protective", 
            "Inheritance": "Recessive", 
            "PMID Count": 5, 
            "PMID List": [
                "7876235", 
                "12692541", 
                "19625485", 
                "20031047", 
                "22025362"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "2", 
                "Penetrance": "5", 
                "Severity": "2", 
                "Treatability": "3"
            }, 
            "Status": "Homozygous", 
            "Summary": "This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are \"non-secretors\": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.", 
            "URL": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "Variant Name": "FUT2-W154X", 
            "Variant Page": "http://evidence.pgp-hms.org/FUT2-W154X", 
            "dbSNP IDs": [
                "rs601338"
            ]
        }, 
        {
            "Allele Frequency": "0.34", 
            "Build 37 Chromosome": "chr20", 
            "Build 37 Position": "4680251", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "PRNP", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "18236005", 
                "19081515"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "4", 
                "Treatability": "1"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.\n\n", 
            "URL": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "Variant Name": "PRNP-M129V", 
            "Variant Page": "http://evidence.pgp-hms.org/PRNP-M129V", 
            "dbSNP IDs": [
                "rs1799990"
            ]
        }, 
        {
            "Allele Frequency": "0.048", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "CCR5", 
            "Impact": "Protective", 
            "Inheritance": "Recessive", 
            "PMID Count": 3, 
            "PMID List": [
                "8751444", 
                "8791590", 
                "8898752"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": "1", 
                "Severity": "4", 
                "Treatability": "4"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Also known as CCR5-delta32, this variant is associated with resistance to many strains of HIV (but not all strains, only strains that use target the CCR5 protein). Heterozygotes are reported to have slower HIV progression, and homozygotes are very resistant to being infected by these strains.", 
            "URL": "http://evidence.pgp-hms.org/CCR5-S185Shift", 
            "Variant Name": "CCR5-S185Shift", 
            "Variant Page": "http://evidence.pgp-hms.org/CCR5-S185Shift", 
            "dbSNP IDs": [
                "rs333"
            ]
        }, 
        {
            "Allele Frequency": "0.3", 
            "Build 37 Chromosome": "chr18", 
            "Build 37 Position": "21140432", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "NPC1", 
            "Impact": "Protective", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 3, 
            "PMID List": [
                "19151714", 
                "19174833", 
                "19910939"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6\" individual).\n\n\n\n\n\n", 
            "URL": "http://evidence.pgp-hms.org/NPC1-H215R", 
            "Variant Name": "NPC1-H215R", 
            "Variant Page": "http://evidence.pgp-hms.org/NPC1-H215R", 
            "dbSNP IDs": [
                "rs1805081"
            ]
        }, 
        {
            "Allele Frequency": "0.21", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "35874575", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Immune system", 
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "IL7R", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 5, 
            "PMID List": [
                "12825072", 
                "17660530", 
                "17660816", 
                "17660817", 
                "21161391"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": "1", 
                "Penetrance": "0", 
                "Severity": "4", 
                "Treatability": "3"
            }, 
            "Status": "Heterozygous", 
            "Summary": "The reference genome variant for this allele has been associated with a slight increased risk of multiple sclerosis. Thus, this variant can be treated as a \"protective\" variant -- carriers of this variant are slightly less likely to have MS. Because the disease is rare and the effect of this variant is not very strong, the absolute decreased risk for carriers of this variant is less than .05% (less than 1 in 2000).", 
            "URL": "http://evidence.pgp-hms.org/IL7R-T244I", 
            "Variant Name": "IL7R-T244I", 
            "Variant Page": "http://evidence.pgp-hms.org/IL7R-T244I", 
            "dbSNP IDs": [
                "rs6897932"
            ]
        }, 
        {
            "Allele Frequency": "0.74", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "17409572", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "KCNJ11", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "17463246", 
                "17463248", 
                "20054294"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "2", 
                "Severity": "3", 
                "Treatability": "4"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is associated with decreased risk of type 2 diabetes. It is unclear whether this variant has additive effects, or acts in a dominant or recessive manner. Assuming diabetes has a lifetime risk of 36%, we estimate a decreased risk of around 1-2% per copy of this variant.", 
            "URL": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "Variant Name": "KCNJ11-K23E", 
            "Variant Page": "http://evidence.pgp-hms.org/KCNJ11-K23E", 
            "dbSNP IDs": [
                "rs5219"
            ]
        }, 
        {
            "Allele Frequency": "0.084", 
            "Build 37 Chromosome": "chr8", 
            "Build 37 Position": "19819724", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "LPL", 
            "Impact": "Protective", 
            "Inheritance": "Unknown", 
            "PMID Count": 6, 
            "PMID List": [
                "16574898", 
                "17463246", 
                "18193044", 
                "19802338", 
                "20429872", 
                "22042884"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": null, 
                "Severity": "1", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant actually increases LPL enzyme activity despite creating a termination codon (see Rip J et al). It appears to be a protective variant, associated with lower triglyceride levels--although the effect is quite weak and explains only 0.5-1% of triglyceride variation.", 
            "URL": "http://evidence.pgp-hms.org/LPL-S474X", 
            "Variant Name": "LPL-S474X", 
            "Variant Page": "http://evidence.pgp-hms.org/LPL-S474X", 
            "dbSNP IDs": [
                "rs328"
            ]
        }, 
        {
            "Allele Frequency": "0.18", 
            "Build 37 Chromosome": "chr22", 
            "Build 37 Position": "51064416", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Well-established", 
            "Gene Symbol": "ARSA", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "2574462"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "2", 
                "Familial": "0", 
                "Functional": "2", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This common variant (HapMap 24.1% allele frequency) causes a loss of a glycosylation site (affecting the size of the protein when studied with gel electrophoresis) but does not affect enzyme activity or stability.", 
            "URL": "http://evidence.pgp-hms.org/ARSA-N350S", 
            "Variant Name": "ARSA-N350S", 
            "Variant Page": "http://evidence.pgp-hms.org/ARSA-N350S", 
            "dbSNP IDs": [
                "rs2071421"
            ]
        }, 
        {
            "Allele Frequency": "0.044", 
            "Build 37 Chromosome": "chr6", 
            "Build 37 Position": "52303361", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "EFHC1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "7668263", 
                "15258581"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": "1", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. OMIM appears to incorrectly interpret literature as linking this variant to juvenile myoclonic epilepsy; the authors report it as a polymorphism.", 
            "URL": "http://evidence.pgp-hms.org/EFHC1-R182H", 
            "Variant Name": "EFHC1-R182H", 
            "Variant Page": "http://evidence.pgp-hms.org/EFHC1-R182H", 
            "dbSNP IDs": [
                "rs3804505"
            ]
        }, 
        {
            "Allele Frequency": "0.057", 
            "Build 37 Chromosome": "chr15", 
            "Build 37 Position": "28230318", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision", 
                "Skin"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "OCA2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "12163334"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with eye color, as is OCA2 R305W. Individuals with this variant are reported to be more likely to have green/hazel eyes as opposed to blue/gray eyes. Other variants in this gene are associated with oculocutaneous albinism (albinism which involves skin and eyes).", 
            "URL": "http://evidence.pgp-hms.org/OCA2-R419Q", 
            "Variant Name": "OCA2-R419Q", 
            "Variant Page": "http://evidence.pgp-hms.org/OCA2-R419Q", 
            "dbSNP IDs": [
                "rs1800407"
            ]
        }, 
        {
            "Allele Frequency": "0.073", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "180057293", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Blood"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "FLT4", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "11292664"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "Other severe variants in this gene are implicated in causing Milroy Disease (primary lymphedema) in a recessive manner. Although this variant is rare (2.3% allele frequency), it is still common enough that it is highly unlikely to have a severe, high penetrance pathogenic effect.", 
            "URL": "http://evidence.pgp-hms.org/FLT4-N149D", 
            "Variant Name": "FLT4-N149D", 
            "Variant Page": "http://evidence.pgp-hms.org/FLT4-N149D", 
            "dbSNP IDs": [
                "rs34221241"
            ]
        }, 
        {
            "Allele Frequency": "0.37", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "6026988", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Likely", 
            "Gene Symbol": "PMS2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15256438"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Benign, common variant.", 
            "URL": "http://evidence.pgp-hms.org/PMS2-P470S", 
            "Variant Name": "PMS2-P470S", 
            "Variant Page": "http://evidence.pgp-hms.org/PMS2-P470S", 
            "dbSNP IDs": [
                "rs1805321"
            ]
        }, 
        {
            "Allele Frequency": "0.078", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "127609633", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "FBN2", 
            "Impact": "Benign", 
            "Inheritance": "Dominant", 
            "PMID Count": 4, 
            "PMID List": [
                "9714438", 
                "10633129", 
                "16835936", 
                "17345643"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign -- initially associated with congenital contractual arachnodactyly, but later reports classify it as a nonpathogenic polymorphism.", 
            "URL": "http://evidence.pgp-hms.org/FBN2-S2580L", 
            "Variant Name": "FBN2-S2580L", 
            "Variant Page": "http://evidence.pgp-hms.org/FBN2-S2580L", 
            "dbSNP IDs": [
                "rs2291628"
            ]
        }, 
        {
            "Allele Frequency": "0.23", 
            "Build 37 Chromosome": "chr14", 
            "Build 37 Position": "21790040", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Hearing and vision"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RPGRIP1", 
            "Impact": "Benign", 
            "Inheritance": "Complex/Other", 
            "PMID Count": 2, 
            "PMID List": [
                "12920076", 
                "16272259"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "2", 
                "Familial": "-1", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. Implicated in causing autosomal recessive cone-rod dystrophy, but a later report found the same incidence in controls and concludes it is not causal.", 
            "URL": "http://evidence.pgp-hms.org/RPGRIP1-A547S", 
            "Variant Name": "RPGRIP1-A547S", 
            "Variant Page": "http://evidence.pgp-hms.org/RPGRIP1-A547S", 
            "dbSNP IDs": [
                "rs10151259"
            ]
        }, 
        {
            "Allele Frequency": "0.011", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "70286631", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "AARS", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "20045102"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "-1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Tentatively presumed benign because seen in a healthy PGP participant. A damaging effect to the gene is predicted by Polyphen 2 and other variants are reported to cause Chacot-Marie-Tooth neuropathy in a dominant manner.", 
            "URL": "http://evidence.pgp-hms.org/AARS-K967M", 
            "Variant Name": "AARS-K967M", 
            "Variant Page": "http://evidence.pgp-hms.org/AARS-K967M", 
            "dbSNP IDs": [
                "rs35744709"
            ]
        }, 
        {
            "Allele Frequency": "0.048", 
            "Build 37 Chromosome": "chr11", 
            "Build 37 Position": "102988504", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "DYNC2H1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/DYNC2H1-Q304L", 
            "Variant Name": "DYNC2H1-Q304L", 
            "Variant Page": "http://evidence.pgp-hms.org/DYNC2H1-Q304L", 
            "dbSNP IDs": [
                "rs12146610"
            ]
        }, 
        {
            "Allele Frequency": "0.041", 
            "Build 37 Chromosome": "chr3", 
            "Build 37 Position": "48623124", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "COL7A1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Polymorphism, presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/COL7A1-P1277L", 
            "Variant Name": "COL7A1-P1277L", 
            "Variant Page": "http://evidence.pgp-hms.org/COL7A1-P1277L", 
            "dbSNP IDs": [
                "rs35761247"
            ]
        }, 
        {
            "Allele Frequency": "0.011", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "53653005", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Anatomical and congenital", 
                "Mental and behavioral", 
                "Nervous system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RPGRIP1L", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19430481"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably not pathogenic, although it may have a modifier effect in other diseases. Other disruptive variants in this gene are implicated in causing Joubert Syndrome and Meckel Syndrome in a recessive manner. Although this variant is somewhat rare (1.1% allele frequency) and Polyphen 2 predicts it to be disruptive, most reported disease-causing variants in the gene are more disruptive frameshift or nonsense mutations & occur upstream of this position.", 
            "URL": "http://evidence.pgp-hms.org/RPGRIP1L-A1183G", 
            "Variant Name": "RPGRIP1L-A1183G", 
            "Variant Page": "http://evidence.pgp-hms.org/RPGRIP1L-A1183G"
        }, 
        {
            "Allele Frequency": "0.22", 
            "Build 37 Chromosome": "chr12", 
            "Build 37 Position": "33021934", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PKP2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19955750"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is a benign polymorphism.  ", 
            "URL": "http://evidence.pgp-hms.org/PKP2-L366P", 
            "Variant Name": "PKP2-L366P", 
            "Variant Page": "http://evidence.pgp-hms.org/PKP2-L366P", 
            "dbSNP IDs": [
                "rs1046116"
            ]
        }, 
        {
            "Allele Frequency": "0.011", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "103234202", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RELN", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "14515139"
            ], 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign.", 
            "URL": "http://evidence.pgp-hms.org/RELN-G1280E", 
            "Variant Name": "RELN-G1280E", 
            "Variant Page": "http://evidence.pgp-hms.org/RELN-G1280E", 
            "dbSNP IDs": [
                "rs55689103"
            ]
        }, 
        {
            "Allele Frequency": "0.038", 
            "Build 37 Chromosome": "chr13", 
            "Build 37 Position": "100962156", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PCCA", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "10101253"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Reported as a polymorphism, tentatively presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/PCCA-I475V", 
            "Variant Name": "PCCA-I475V", 
            "Variant Page": "http://evidence.pgp-hms.org/PCCA-I475V", 
            "dbSNP IDs": [
                "rs35719359"
            ]
        }, 
        {
            "Allele Frequency": "0.094", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "115231254", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "AMPD1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15173240"
            ], 
            "Scores": {
                "Case/Control": "0", 
                "Computational": "0", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign, ancestral to15173240 pathogenic Q12X mutation.", 
            "URL": "http://evidence.pgp-hms.org/AMPD1-P48L", 
            "Variant Name": "AMPD1-P48L", 
            "Variant Page": "http://evidence.pgp-hms.org/AMPD1-P48L", 
            "dbSNP IDs": [
                "rs61752479"
            ]
        }, 
        {
            "Allele Frequency": "0.35", 
            "Build 37 Chromosome": "chr8", 
            "Build 37 Position": "55539395", 
            "Build 37 Variant Allele": "T", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Metabolism"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "RP1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12764676", 
                "19364639"
            ], 
            "Scores": {
                "Case/Control": "4", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "Probably benign. One report linked this variant to high triglycerides, but a later paper found a nearby SNP with similar association and suggests that both findings are caused by linkage to an undiscovered causal variant.", 
            "URL": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "Variant Name": "RP1-N985Y", 
            "Variant Page": "http://evidence.pgp-hms.org/RP1-N985Y", 
            "dbSNP IDs": [
                "rs2293869"
            ]
        }, 
        {
            "Allele Frequency": "0.69", 
            "Build 37 Chromosome": "chr5", 
            "Build 37 Position": "33951693", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Cancer"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "SLC45A2", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 4, 
            "PMID List": [
                "15714523", 
                "17044855", 
                "18563784", 
                "18806926"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": null, 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Homozygous", 
            "Summary": "Pigmentation allele for non-black hair, and consequently, possible increased susceptibility to malignant melanoma.", 
            "URL": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "Variant Name": "SLC45A2-L374F", 
            "Variant Page": "http://evidence.pgp-hms.org/SLC45A2-L374F", 
            "dbSNP IDs": [
                "rs16891982"
            ]
        }, 
        {
            "Allele Frequency": "0.43", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "141673345", 
            "Build 37 Variant Allele": "G", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TAS2R38", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 3, 
            "PMID List": [
                "12595690", 
                "15883422", 
                "20675712"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "1", 
                "Familial": "5", 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is strongly associated with causing the \"taster\" phenotype of phenylthiocarbamine (PTC) in a dominant manner.", 
            "URL": "http://evidence.pgp-hms.org/TAS2R38-A49P", 
            "Variant Name": "TAS2R38-A49P", 
            "Variant Page": "http://evidence.pgp-hms.org/TAS2R38-A49P", 
            "dbSNP IDs": [
                "rs713598"
            ]
        }, 
        {
            "Allele Frequency": "0.46", 
            "Build 37 Chromosome": "chr7", 
            "Build 37 Position": "141672604", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "TAS2R38", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "12595690", 
                "20675712"
            ], 
            "Scores": {
                "Case/Control": "2", 
                "Computational": "2", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "This variant is associated with \"taster\" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.", 
            "URL": "http://evidence.pgp-hms.org/TAS2R38-I296V", 
            "Variant Name": "TAS2R38-I296V", 
            "Variant Page": "http://evidence.pgp-hms.org/TAS2R38-I296V", 
            "dbSNP IDs": [
                "rs10246939"
            ]
        }, 
        {
            "Allele Frequency": "0.16", 
            "Build 37 Chromosome": "chr10", 
            "Build 37 Position": "13340236", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Nervous system"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PHYH", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 2, 
            "PMID List": [
                "10767344", 
                "14974078"
            ], 
            "Scores": {
                "Case/Control": "3", 
                "Computational": "1", 
                "Familial": "0", 
                "Functional": null, 
                "Penetrance": "0", 
                "Severity": "0", 
                "Treatability": "0"
            }, 
            "Status": "Heterozygous", 
            "Summary": "Probably benign. This variant was implicated as causing Refsum Disease in a recessive manner, but a subsequent publication noted that all instances were linked with other explanatory mutations. The high allele frequency of this variant in the population (7-13%) contradicts a pathogenic hypothesis.", 
            "URL": "http://evidence.pgp-hms.org/PHYH-P29S", 
            "Variant Name": "PHYH-P29S", 
            "Variant Page": "http://evidence.pgp-hms.org/PHYH-P29S", 
            "dbSNP IDs": [
                "rs28938169"
            ]
        }, 
        {
            "Allele Frequency": "0.89", 
            "Build 37 Chromosome": "chr1", 
            "Build 37 Position": "55529187", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PCSK9", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "19351729"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "3", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This variant is likely benign. ", 
            "URL": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "Variant Name": "PCSK9-G670E", 
            "Variant Page": "http://evidence.pgp-hms.org/PCSK9-G670E", 
            "dbSNP IDs": [
                "rs505151"
            ]
        }, 
        {
            "Allele Frequency": "0.048", 
            "Build 37 Chromosome": "chr16", 
            "Build 37 Position": "28950051", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "CD19", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "1", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/CD19-R514H", 
            "Variant Name": "CD19-R514H", 
            "Variant Page": "http://evidence.pgp-hms.org/CD19-R514H", 
            "dbSNP IDs": [
                "rs34763945"
            ]
        }, 
        {
            "Allele Frequency": "1.0", 
            "Build 37 Chromosome": "chr2", 
            "Build 37 Position": "21235475", 
            "Build 37 Variant Allele": "C", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "APOB", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 0, 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "5", 
                "Familial": "0", 
                "Functional": "0", 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Homozygous", 
            "Summary": "This position is almost certainly an error in the HG18 reference sequence. ", 
            "URL": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "Variant Name": "APOB-Y1422C", 
            "Variant Page": "http://evidence.pgp-hms.org/APOB-Y1422C", 
            "dbSNP IDs": [
                "rs568413"
            ]
        }, 
        {
            "Allele Frequency": "0.3", 
            "Build 37 Chromosome": "chr9", 
            "Build 37 Position": "98209594", 
            "Build 37 Variant Allele": "A", 
            "Build37 coordinates:": [], 
            "Clinical Importance": "Low", 
            "Condition Tags": [
                "Other"
            ], 
            "Evidence": "Uncertain", 
            "Gene Symbol": "PTCH1", 
            "Impact": "Benign", 
            "Inheritance": "Unknown", 
            "PMID Count": 1, 
            "PMID List": [
                "15712338"
            ], 
            "Scores": {
                "Case/Control": "5", 
                "Computational": "-1", 
                "Familial": null, 
                "Functional": null, 
                "Penetrance": null, 
                "Severity": null, 
                "Treatability": null
            }, 
            "Status": "Heterozygous", 
            "Summary": "Common polymorphism, presumed benign.", 
            "URL": "http://evidence.pgp-hms.org/PTCH1-P1315L", 
            "Variant Name": "PTCH1-P1315L", 
            "Variant Page": "http://evidence.pgp-hms.org/PTCH1-P1315L", 
            "dbSNP IDs": [
                "rs357564"
            ]
        }
    ]
}